Fiona Thomson

University of Glasgow — United Kingdom

Biochemistry, Genetics and Molecular Biology · Life Sciences

26h-index2.7kcitations362works3.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Protein Kinase Regulation and GTPase Signaling(16), Neuroendocrine regulation and behavior(15), Stress Responses and Cortisol(12), Electroconvulsive Therapy Studies(11), Attention Deficit Hyperactivity Disorder(10)

Publications102 total

Correction: Relative telomere length and senescence-associated inflammatory cytokines as blood-based prognostic markers in patients with advanced or resectable gastro-oesophageal adenocarcinoma
British Journal of Cancer·2025Open Access
Relative telomere length and senescence-associated inflammatory cytokines as blood-based prognostic markers in patients with advanced or resectable gastro-oesophageal adenocarcinoma
British Journal of Cancer·2025Open Access
General practice pharmacist-led antipsychotic physical health monitoring: a prospective intervention scoping study
Family Practice·2024· 9 citedOpen Access
The Scottish Mesothelioma Network: Impact of a national MDT on overall survival in pleural mesothelioma
2023· 3 cited
The Scottish Mesothelioma Network: impact of a national multidisciplinary team on overall survival in malignant pleural mesothelioma
Lung Cancer·2023· 3 cited
A phase I/II study of the CXCR2 inhibitor, AZD5069, in combination with durvalumab, in patients (pts) with advanced hepatocellular carcinoma (HCC).
Journal of Clinical Oncology·2023· 15 cited
Correction to: Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT)
Radiation Oncology·2021Open Access
FP12.04 Obesity is Associated With Greater Overall Survival in Patients With Metastatic NSCLC Receiving First-Line Pembrolizumab
Journal of Thoracic Oncology·2021Open Access
P57.07 The Scottish Immunotherapy Prognostic Score (SIPS) Predicts Response to First-Line Pembrolizumab for Metastatic Non-Small Cell Lung Cancer
Journal of Thoracic Oncology·2021· 1 cited
Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT)
Radiation Oncology·2021· 17 citedOpen Access
Serum Proteomics and Plasma Fibulin-3 in Differentiation of Mesothelioma From Asbestos-Exposed Controls and Patients With Other Pleural Diseases
Journal of Thoracic Oncology·2021· 19 citedOpen Access
SAPROCAN: Saracatinib (AZD0530) and docetaxel in metastatic,castrate-refractory prostate cancer (mCRPC)—A phase I/randomized phase II study by the United Kingdom National Cancer Research Institute Prostate Group.
Journal of Clinical Oncology·2021· 2 cited
Optimisation of an Electrochemical DNA Sensor for Measuring KRAS G12D and G13D Point Mutations in Different Tumour Types
Biosensors·2021· 22 citedOpen Access
Additional file 1 of Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT)
Figshare·2021Open Access
Electrochemical DNA Detection Methods to Measure Circulating Tumour DNA for Enhanced Diagnosis and Monitoring of Cancer
2020· 1 citedOpen Access
Development of electrochemical DNA detection methods to measure circulating tumour DNA for enhanced diagnosis and monitoring cancer
Strathprints: The University of Strathclyde institutional repository (University of Strathclyde)·2020
Developing a Low-Cost, Simple-to-Use Electrochemical Sensor for the Detection of Circulating Tumour DNA in Human Fluids
Biosensors·2020· 19 citedOpen Access
Discovery of [<sup>11</sup>C]MK-6884: A Positron Emission Tomography (PET) Imaging Agent for the Study of M4Muscarinic Receptor Positive Allosteric Modulators (PAMs) in Neurodegenerative Diseases
Journal of Medicinal Chemistry·2020· 39 citedOpen Access
Pharmacological Characterization of the Novel and Selective α7 Nicotinic Acetylcholine Receptor–Positive Allosteric Modulator BNC375
Journal of Pharmacology and Experimental Therapeutics·2020· 16 citedOpen Access
TPL Clinical Trials Records
2020
page 1 of 6Next →

Frequent Co-authors

Mark Craighead(9), Cliona MacSweeney(7), Rory Mitchell(6), Francesca Spiga(5), Stafford L. Lightman(5), Richard Goodwin(4), Gwyn W. Gould(4), E. A. Masson(4), Caroline Kelly(4), M. S. Johnson(4), David J. MacEwan(4), Morag A. Grassie(3), Robin Plevin(3), Jason M. Uslaner(3), Louise Harrison(3), Melanie S. Johnson(3), Jeremy Presland(3), Lorraine McIntosh(2), Andrew J.M. Boulton(2), Louise M. Perkins(2)